Back to company

ABBLO PHARMA ApS: Financial statements 2022

CVR: 34080534

ABBLO PHARMA ApS (CVR 34080534) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,056,147 and a net result of DKK 300,769 compared with DKK 285,238 the year before. That is an increase of 42.6% compared with the year before. Equity amounted to DKK -328,422. The company had 1 employee in the financial year.

Gross Profit
1,056,147 kr.
Profit/Loss
300,769 kr.
Equity
-328,422 kr.
Total Assets
1,161,691 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-1.1 mio.301 t.-328 t.1
2021-740 t.285 t.-629 t.1
2020-376 t.214 t.-914 t.1
2019-306 t.100 t.-1.1 mio.1
2018-146 t.12 t.-1.2 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on ABBLO PHARMA ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

ABBLO PHARMA ApS: The 2021 annual report is outFeb 25, 2022

ABBLO PHARMA ApS has published its annual report for 2021. Gross profit came to DKK 740,462, and the net result was DKK 285,238.

About ABBLO PHARMA ApS

ABBLO PHARMA ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2011. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Nic Borch-Christensen and Mie Hjerrild Petersen. The company is owned by ABBLO S.à.r.l. The company has 0 employees. In 2025, the company reported a gross profit of DKK 471,866 and a net result of DKK -152,259 compared with DKK 135,215 the year before. Equity amounted to DKK -238,088.